Q3 2021 Holdings
Filed 2021-11-15 | 173 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $253.1M | 5,833,600 | 20.6% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $227.4M | 5,383,500 | 18.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $153.2M | 1,420,600 | 12.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $145.1M | 6,073,850 | 11.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $83.8M | 4,180,768 | 6.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $66.3M | 234,200 | 5.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $63.1M | 2,996,876 | 5.1% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $41.2M | 1,923,139 | 3.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $33.6M | 6,943,654 | 2.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $25.9M | 1,146,145 | 2.1% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $23.4M | 2,648,386 | 1.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $22.4M | 414,300 | 1.8% |
| Cvrx Inc(CVRX) | COM | 126638105 | $13.2M | 799,861 | 1.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.7M | 651,783 | 1.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $11.1M | 150,000 | 0.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $10.2M | 407,047 | 0.8% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $10.2M | 346,262 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.3M | 1,821,868 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.6M | 110,900 | 0.7% |
| Adagene Inc(ADAG) | ADS | 005329107 | $4.0M | 275,000 | 0.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.7M | 302,509 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $382.4K | 6,028,307 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $313.7K | 10,039,691 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $285.9K | 2,610,355 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $280.3K | 3,732,400 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $267.2K | 4,515,400 | 0.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $255.9K | 11,895,652 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $242.9K | 1,373,200 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $231.5K | 13,944,680 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $218.4K | 7,330,423 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $175.3K | 1,572,800 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $163.9K | 6,645,100 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $159.2K | 877,400 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $156.9K | 2,361,327 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $153.4K | 1,227,400 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $152.3K | 389,700 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $138.8K | 139,600 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $134.0K | 1,065,700 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $130.4K | 335,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $127.5K | 1,126,400 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $124.7K | 228,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $114.3K | 1,192,015 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $109.4K | 7,884,870 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $96.7K | 660,800 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $89.0K | 337,400 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $88.6K | 3,847,929 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $87.2K | 8,740,887 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $87.2K | 3,322,488 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $84.5K | 14,897,914 | 0.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $80.9K | 72,873,494 | 0.0% |